-+ 0.00%
-+ 0.00%
-+ 0.00%
ISE Chemicals (TSE:4107) Stock Premium Looks Harder To Defend After Margin Slip
Share
Listen to the news

ISE Chemicals walked into this earnings day with a premium tag and a bruised share chart. The stock closed at ¥3,380, well above a discounted cash flow estimate of ¥2,478.79, even after double digit declines over the past week and quarter. The headline from the quarter is simple: profitability looks a touch thinner while investors are still paying up for it.

Net margin on trailing numbers sits at 15.3% versus 16.5% a year earlier, yet the stock still trades on a 28.7x P/E, ahead of both peers and the broader Japan chemicals sector. That tension is what the market is really reacting to today.

Love the premium multiple on ISE Chemicals but concerned about thinner margins and valuation risk at these levels? Check out our 60 resilient stocks with low risk scores to compare it with companies that offer more modest pricing and resilient risk profiles.

Q2 2026 Earnings Summary

  • Revenue (Q2 2026 vs. Q2 2025): ¥10,424 million vs. ¥11,047 million (declined 5.6%)
  • Net Income (Excl. Extra Items, Q2 2026 vs. Q2 2025): ¥1,497 million vs. ¥1,955 million (declined 23.4%)
  • Basic EPS (Earnings Per Share, Q2 2026 vs. Q2 2025): ¥29.38 vs. ¥38.36 (declined 23.4%)
  • Trailing Net Margin (Latest vs. Prior Year): 15.3% vs. 16.5% (compressed 1.2 percentage points)

If you prefer clean charts instead of a dense block of earnings figures and ratios, you can see ISE Chemicals in one visual, including how its valuation compares, in the company report for ISE Chemicals.

TSE:4107 Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026
TSE:4107 Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026

Where The ISE Chemicals Bull Story Still Holds

The bullish story around ISE Chemicals as a niche iodine and specialty materials supplier finds some support in these results, but with caveats. Margins remain in double digits at 15.3%, which is consistent with a specialty profile rather than a commodity producer. The new US iodine project with Select Water Solutions also fits the idea of an expanded resource base over time. However, the 5.6% revenue decline and 23.4% fall in net income and EPS suggest the business is not currently on a clear growth track.

Why The Bearish Concerns Look More Concrete

The bear case around ISE Chemicals has more near term backing from the numbers. Revenue, net income and EPS all declined year on year, and net margin compressed from 16.5% to 15.3%. That points to softer profitability on existing operations. The share price has also fallen over 30% in 90 days, which indicates investors are already reacting to this weaker trend. The long dated iodine expansion in North America may be encouraging, but it does not offset the immediate pressure seen in the latest quarter.

With revenue, earnings and margins all under pressure, plus a share price that has swung sharply in recent months, it is fair to ask whether this is just short term noise or a sign of deeper fragility in ISE Chemicals. Review the independent risk analysis for ISE Chemicals which shows 1 important warning sign

Stay Ahead With Simply Wall St

If the premium P/E and recent share price swings around ISE Chemicals have your attention, register for free with Simply Wall St and add it to your Watchlist to track the share price against fair value and wait for an entry point that fits your risk appetite. After you invest, use the Portfolio Command Center to cut through market noise and focus on the updates that matter most for your holdings. For longer term conviction building, tap into shared research and debate through the Community to see how other investors are thinking about opportunities and risks. By surfacing potential catalysts and red flags early, you give yourself a better chance of staying ahead of the market.

Seeking Alternatives Beyond ISE Chemicals?

Fresh ideas often move first. Before the best entry points get caught by fast money and the story goes mainstream, scan these focused stock lists while it matters and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending